Literature DB >> 22698901

Gyrate atrophy of the choroid and retina with hyperornithinemia, cystinuria and lysinuria responsive to vitamin B6.

Fatos Tanzer1, Mehtap Firat, Meral Alagoz, Haydar Erdogan.   

Abstract

In this report, an 8-year-old girl is presented with the complaint of progressive night blindness. The authors have performed eye funduscopy, which showed chorioretinal atrophy in gyrate shape. A high level of plasma ornithine was determined. Urinary excretion of ornithine as well as lysine and cystine were increased. Patient was treated with high dose pyridoxine supplement (500 mg/dl). The night blindness condition of the patient improved. After 1 month of pyridoxine therapy ornithine level of her plasma was successfully reduced and blindness improved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22698901      PMCID: PMC3063262          DOI: 10.1136/bcr.07.2010.3200

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Use of an arginine-restricted diet to slow progression of visual loss in patients with gyrate atrophy.

Authors:  Muriel I Kaiser-Kupfer; Rafael C Caruso; David Valle; George F Reed
Journal:  Arch Ophthalmol       Date:  2004-07

2.  Genetic aspects in gyrate atrophy of the choroid and retina with hyperornithinaemia.

Authors:  K Takki; O Simell
Journal:  Br J Ophthalmol       Date:  1974-11       Impact factor: 4.638

3.  Raised plasma-ornithine and gyrate atrophy of the choroid and retina.

Authors:  O Simell; K Takki
Journal:  Lancet       Date:  1973-05-12       Impact factor: 79.321

4.  Pyridoxine-responsive genetic disease.

Authors:  S H Mudd
Journal:  Fed Proc       Date:  1971 May-Jun

5.  Gyrate atrophy of the choroid and retina. Early findings.

Authors:  M I Kaiser-Kupfer; I H Ludwig; F M de Monasterio; D Valle; I Krieger
Journal:  Ophthalmology       Date:  1985-03       Impact factor: 12.079

6.  A specific enzyme defect in gyrate atrophy.

Authors:  M I Kaiser-Kupfer; D Valle; L A Del Valle
Journal:  Am J Ophthalmol       Date:  1978-02       Impact factor: 5.258

7.  Systemic manifestations of gyrate atrophy of the choroid and retina.

Authors:  M I Kaiser-Kupfer; T Kuwabara; V Askanas; L Brody; K Takki; I Dvoretzky; W K Engel
Journal:  Ophthalmology       Date:  1981-04       Impact factor: 12.079

8.  Clinical trial of vitamin B6 for gyrate atrophy of the choroid and retina.

Authors:  R G Weleber; N G Kennaway
Journal:  Ophthalmology       Date:  1981-04       Impact factor: 12.079

9.  Low-protein diet and progression of retinal degeneration in gyrate atrophy of the choroid and retina: a twenty-six-year follow-up.

Authors:  R Santinelli; C Costagliola; C Tolone; A D'Aloia; A D'Avanzo; F Prisco; L Perrone; E Miraglia del Giudice
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

10.  Cataract in gyrate atrophy: clinical and morphologic studies.

Authors:  M Kaiser-Kupfer; T Kuwabara; S Uga; K Takki; D Valle
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-04       Impact factor: 4.799

View more
  3 in total

1.  OAT mutations and clinical features in two Japanese brothers with gyrate atrophy of the choroid and retina.

Authors:  Satoshi Katagiri; Tamaki Gekka; Takaaki Hayashi; Hiroyuki Ida; Toya Ohashi; Yoshikatsu Eto; Hiroshi Tsuneoka
Journal:  Doc Ophthalmol       Date:  2014-01-16       Impact factor: 2.379

2.  Multimodal characterization of a novel mutation causing vitamin B6-responsive gyrate atrophy.

Authors:  Xuan Cui; Ruben Jauregui; Karen Sophia Park; Stephen H Tsang
Journal:  Ophthalmic Genet       Date:  2018-05-14       Impact factor: 1.803

Review 3.  Ornithine Aminotransferase, an Important Glutamate-Metabolizing Enzyme at the Crossroads of Multiple Metabolic Pathways.

Authors:  Antonin Ginguay; Luc Cynober; Emmanuel Curis; Ioannis Nicolis
Journal:  Biology (Basel)       Date:  2017-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.